Deborah Quinn

2015

In 2015, Deborah Quinn earned a total compensation of $550.4K as Chief Medical Officer at Bellerophon Therapeutics.

Compensation breakdown

Bonus$195,000
Option Awards$68,414
Salary$271,154
Stock Awards$5,476
Other$10,361
Total$550,405

Quinn received $271.2K in salary, accounting for 49% of the total pay in 2015.

Quinn also received $195K in bonus, $68.4K in option awards, $5.5K in stock awards and $10.4K in other compensation.

Rankings

In 2015, Deborah Quinn's compensation ranked 10,455th out of 13,638 executives tracked by ExecPay. In other words, Quinn earned more than 23.3% of executives.

ClassificationRankingPercentile
All
10,455
out of 13,638
23rd
Division
Manufacturing
3,987
out of 5,187
23rd
Major group
Chemicals And Allied Products
1,471
out of 1,857
21st
Industry group
Drugs
1,211
out of 1,531
21st
Industry
Pharmaceutical Preparations
942
out of 1,179
20th
Source: SEC filing on March 20, 2017.

Quinn's colleagues

We found five more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2015.

2015

Jonathan Peacock

Bellerophon Therapeutics

Chief Executive Officer

2015

Martin Meglasson

Bellerophon Therapeutics

Chief Scientific Officer

2015

Reinilde Heyrman

Bellerophon Therapeutics

former Chief Clinical Development Officer

2015

Martin Dekker

Bellerophon Therapeutics

Vice President of Device Engineering and Manufacturing

2015

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

You may also like